10
Total investments
4
Early stage
2
Mid stage
0
Late stage
10y
Years active
Portfolio
6 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Jun 2018
Mi Padrino was a marketplace that makes planning Hispanic celebrations easy and effective. https://youtu.be/cWOHq984o6c
Mi Padrino was successfully acquired in 2022
Investor
Jun 2017
Entrepreneurs and agencies go to co-pilot with proposals, invoices, and teammates all in one place. Get started for free today.
Investor
Jun 2017
BlendScore is the Moodys of corporate DEI. By collecting and analyzing tens of thousands of ESG-related data sets, we provide enterprise solutions to manage risk, branding, and compliance.
Investor
Mar 2017
With mobile beauty & wellness services generating $8.1 billion in spending annually, BeautyLynk is rethinking the growing industry by offering women of all backgrounds beauty at their doorsteps. BeautyLynk brings the salon to the client by providing convenient online booking and deploying beauty professionals to the client's location.
These services are performed by BeautyLynk’s team of hand-picked professionals and include everything from the basics (blowouts) to the advanced (bridal makeovers) to the culturally-specific (Marley twists.) Our personalized appointment structure ensures that each client gets the VIP treatment she deserves, regardless of hair texture or skin complexion. And, on average, our professionals earn up to 40% more per service than they would at a salon.
Founded in 2015 with hubs in Boston & NYC, BeautyLynk is committed to helping beauty professionals earn more money and freedom, while helping women of all backgrounds feel beautiful, included and empowered.
Investor
Feb 2017
ENB Therapeutics is developing therapies to break drug resistance that occurs in over 50% of cancer patients. Our lead product, ENB-001, is a first-in-class, selective small molecule endothelin B receptor (ETBR) inhibitor shown in multiple preclinical studies to significantly reduce tumor growth and prolong survival in cancer animal models. ENB-001 is the key to unlock the full therapeutic potential of immunotherapy by restoring the ability of T-cells to infiltrate tumors, inhibiting metastasis and prolonging patient survival. Granted Orphan Drug Designation by FDA in 2016, ENB-001 has solid market exclusivity and strong IP. A low cost, time efficient development program provides near-term POC within 18 months from financing. A companion diagnostic will detect ETBR pathway over-expressers creating additional opportunities for indication expansion into multiple tumor types and broader participation in the multi-billion-dollar immunotherapy market.
Investor
Jan 2017
The age of solar has arrived.
With prices falling by 80% in less than a decade, solar power is now within reach of every American household.
Here’s the problem: 90 million American households are currently locked out of the solar marketplace. Maybe it’s because they rent their homes. Or other solar companies are not willing to sell to them. Or simply because their roof is in the shade or is not well-suited to a solar array.
Our mission is to unlock the possibility of solar power for these households.
With the help of transformative policies taking root in the United States, we are now in a position to do so. Its called "community solar." What it means is that a household can buy solar power without having an array installed on its roof.
Heres what we noticed: in communities all across the country, there are extraordinary organizations -- from the church down the street to the college campus across town -- that are embracing clean energy and want to bring it to their constituents. There are also households that want to go solar but do not have an easy way to do so. Finally, there are solar companies eager to find more customers.
Our goal as Solstice is to use community solar to help these groups meet one another.
When we do, everybody wins: those who cannot currently access solar are brought into the market, more solar is deployed, and everyone saves on their electricity bills.
Experience · 12 entries
All (12)
Investments (9)
Founder (2)
2018
Investor
Jun 2018
Mi Padrino was a marketplace that makes planning Hispanic celebrations easy and effective. https://youtu.be/cWOHq984o6c
Mi Padrino was successfully acquired in 2022
Business Development and Strategic Partnership Executive
May 2018
At IBM, we do more than work. We create. We create as technologists, developers, and engineers. We create with our partners. We create with our competitors. If youre searching for ways to make the world work better through technology and infrastructure, software and consulting, then we want to work with you.
Were here to help every creator turn their "what if" into what is. Lets create something that will change everything.
P
Portfolia FemTech Fund
Investor
Apr 2018
2017
U
UnaliWear
Investor
Dec 2017
Investor
Jun 2017
Entrepreneurs and agencies go to co-pilot with proposals, invoices, and teammates all in one place. Get started for free today.
Show all 12 entries ↓
Investment activity
2016–2018 · 10 investments
Recent (last 2 years)Earlier
